article · Scientific African
Commiphora gileadensis L. (CG) is traditionally utilized in Arabian and African folk medicine for its antimicrobial and wound-healing properties. Its resinous exudates and essential oils are rich in volatile compounds, but the anti-virulence potential of its cell sap (CG-CS) remains underexplored. This research aimed to profile the volatile constituents of CG-CS using GC-MS and assess its antibacterial, anti-biofilm, and anti-virulence activities against various Gram-positive and Gram-negative pathogens. A total of 107 volatiles were detected in CG-CS, belonging to monoterpene hydrocarbons (39.77%), alcohols (22.39%), and sesquiterpene hydrocarbons (18.09%). Key compounds such as sabinene, myrcene, α-pinene, p-cymene-8-ol, and spathulenol exhibited significant antibacterial activity, with MICs as low as 64 µg/mL, compared to ampicillin and kanamycin . CG-CS and its major constituents disrupted bacterial membranes and inhibited efflux pump function. At sub-inhibitory concentrations, they significantly reduced violacein production, biofilm formation, and secretion of virulence factors, i.e., proteases and hemolysins in S. aureus, P. aeruginosa, K. pneumoniae , and A. baumannii . Notably, CG-CS exhibited superior efficacy, suggesting promising complementary antibacterial activities of the complex volatile oil mixture. In conclusion , CG-CS and its major components demonstrated potential antibacterial and anti-virulence activities, primarily through membrane disruption and interference with QS-regulated pathways, especially for both hydrocarbon and alcohol monoterpenes. The obtained results support the traditional use of C. gileadensis as an antibacterial and warrant the development of a pharmaceutical formulation for further in vivo studies.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.sciaf.2026.e03528
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.